To elucidate the interaction of SIGLEC9 with T-cell and MUC1, firstly, the authors used IHC and IF to verify MUC1 in patients with cervical cancer, and cells were upregulated (Fig. 7A‒B). This evidence concerns the gene SIGLEC9 and cervical cancer.